Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fureasu Co.,Ltd. (7062.T)
Tokyo, JP
Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corporate massage, and specialized support tailored for individuals with visual impairments. Beyond its bodywork segment, the company delivers a broad spectrum of in-home and institutional care services. This includes comprehensive small-scale multi-functional home nursing, domiciliary care visits, day-care transportation, and overnight respite programs. Fureasu also operates home-visit nursing services and manages medical care facilities, further providing personal care assistance for daily living activities like eating, excretion, and bathing. Established in 2000, Fureasu Co.,Ltd. is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.70% | -2.22% | -4.46% | -3.30% | -0.50% | -1.00% | +22.22% | -14.38% | -10.20% | -76.81% | -76.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%+0.7% Q1'26: -27.2% (vs Q1'25)
-
EPS growth Personal Products & Services: +19.6%+288.0% ★ Q1'26: +305.9% (vs Q1'25)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+3.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Personal Products & Services: +10.5%+3.8% Q1'26: +7.3% (vs Q1'25)
-
ROIC Personal Products & Services: +6.9%+8.6% ★ Q1'26: +16.0% (vs Q1'25)
-
Share dilution Personal Products & Services: +0.0%+10.7% Q1'26: +13.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×4.42× Q1'26: 2.65× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
|---|---|---|---|---|
| Revenue |
3.72B
est.
|
3.96B
est: 3.98B (-0.4%)
|
3.67B
est: 4.40B (-16.5%)
|
4.17B
est: 5.00B (-16.5%)
|
| EBITDA |
188.84M
est.
|
140.99M
est: 202.17M (-30.3%)
|
177.24M
est: 223.51M (-20.7%)
|
332.47M
est: 253.99M (+30.9%)
|
| EBIT |
106.25M
est.
|
122.49M
est: 113.76M (+7.7%)
|
123.69M
est: 125.76M (-1.6%)
|
264.97M
est: 142.91M (+85.4%)
|
| Net Income |
228.51M
est.
|
56.88M
est: 20.29M (+180.3%)
|
59.32M
est: 81.16M (-26.9%)
|
147.85M
est: 182.38M (-18.9%)
|
| SGA |
1.64B
est.
|
1.65B
est: 1.76B (-6.0%)
|
1.59B
est: 1.94B (-18.3%)
|
1.83B
est: 2.21B (-17.2%)
|
| EPS |
96.85
est.
|
24.48
est: 8.60 (+184.7%)
|
25.44
est: 34.40 (-26.0%)
|
63.30
est: 77.30 (-18.1%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shinichiro Sekine | Executive Officer & Head of Finance and Accounting Department | — | — |
| Taku Sawanobori | President, Chief Executive Officer & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7062.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
